Clinical update: new treatments for age-related macular degeneration-Reference-Cited by-同舟云学术

Clinical update: new treatments for age-related macular degeneration

Published:2007-07 Issue:9583 Volume:370 Page:204-206
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wong Tien Y,Liew Gerald,Mitchell Paul

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Pegaptanib for neovascular age-related macular degeneration;Gragoudas;N Engl J Med,2004

2. Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration;Ophthalmology,2007

3. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

4. Ranibizumab versus Verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

5. Evolving European guidance on the medical management of neovascular age related macular degeneration;Chakravarthy;Br J Ophthalmol,2006

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POOR VISUAL ACUITY;Retina;2024-09

2. Effect of artesunate on the expression of ICAM-1 and MMP-9 in vascular endothelial cells under high glucose conditions;2024-08-13

3. Potential Risk Factors for Ocular Pain in Patients Undergoing Multiple Intravitreal Injections of Anti-Vascular Endothelial Growth Factor;Clinical Ophthalmology;2024-06

4. International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials;Ophthalmology;2024-06

5. Sulfated CXCR3 Peptide Trap Use as a Promising Therapeutic Approach for Age-Related Macular Degeneration;Biomedicines;2024-01-22